01 mar: Sjælsø Gruppen A/S' årsregnskabsmeddelelse for 2010
01 mar: FormueEvolution I A/S - Insiderer handel
01-03-2011 09:00:00

Cerner Fulfills CE Marking Requirements for Medical Device Connectivity Solution

Cerner CareAware iBus Solution Approved to be Offered in the European Union

KANSAS CITY, Mo., 2011-03-01 09:00 CET (GLOBE NEWSWIRE) --Cerner Corporation today announced that the CareAware iBus has received CE

Marking certification from BSI on the basis of examination under Council

Directive 93/42/EEC Annex II Section 3.2.

The Cerner CareAware iBus solution connects important medical device

information about patient health from disparate systems to the patient's

electronic health record (EHR). This solution will be immediately available to

healthcare organizations in the EU allowing them to access medical information

from medical devices and EHRs to make informed care decisions.

"As a global leader in the development of device connectivity and workflow

solutions, we are excited to extend the offering of our CareAware iBus solution

into the European market," said Tom Herzog, Cerner vice president for IT and

healthcare devices. "Connecting medical devices to the patient's EHR supports

healthcare interoperability, enabling patients and caregivers to access the

right information at the right time."

The Cerner CareAware iBus solution works to improve clinician workflow and

patient safety by:

-- Reducing time spent manually transcribing device data into the EHR,

allowing clinicians to spend more time on direct patient care;

-- Decreasing the chance of medication errors by virtually eliminating manual

data entry errors and increasing the accuracy of data;

-- Providing the ability to automatically perform calculations on medical

device data, including trending capabilities for various sources of

information like heart rate and blood pressure;

-- Reducing interface implementation and maintenance costs through efficient

management of medical device deployment; and

-- Improving monitoring abilities of device performance, connectivity status

and device utilization.

The Cerner CareAware iBus solution provides additional functionality and

workflow benefits. Plug-and-play capabilities for connecting medical devices to

any EHR system allow medical devices to connect to the Cerner CareAware iBus

much like a USB port that quickly and easily connects peripheral devices to a

computer. Once a device is connected, it is immediately recognized and can

begin transmitting patient data to the EHR. The solution also allows waveform

data to be transmitted directly into the EHR. Clinicians may then analyze the

patient's device data in the context of other clinically relevant data for a

specific time period, enabling them to make the best informed care decisions

with all relevant information easily accessible from multiple medical devices.

About Cerner

Cerner is transforming healthcare by eliminating error, variance and waste for

healthcare providers and consumers around the world. Cerner® solutions optimize

processes for healthcare organizations ranging in size from single-doctor

practices, to health systems, to entire countries, for the pharmaceutical and

medical device industries, employer health and wellness services industry and

for the healthcare commerce system. These solutions are licensed by

approximately 9,000 facilities around the world, including more than 2,600

hospitals; 3,500 physician practices covering more than 30,000 physicians; 500

ambulatory facilities, such as laboratories, ambulatory centers, cardiac

facilities, radiology clinics and surgery centers; 800 home health facilities;

and 1,600 retail pharmacies. The trademarks, service marks and logos

(collectively, the "Marks") set forth herein are owned by Cerner Corporation

and/or its subsidiaries in the United States and certain other countries

throughout the world. Nasdaq:CERN. For more information about Cerner, please

visit www.cerner.com, Twitter, Facebook, and YouTube .

CONTACT: Cerner Media Contact:

Kelly Johnson

+1-816-777-8466

kelly.johnson@cerner.com

Cerner Investors Contact:

Allan Kells

+1-816-201-2445

akells@cerner.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
26 okt
VWS
Fra tid til anden lytter jeg til Solveig Bjørnestad’s P1 Business. Hun er dygtig til at lave en 360 ..
36
27 okt
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
26
28 okt
I:SP500
Det ser grundlæggende ganske fint ud makroøkonomisk, hvilket ikke er det samme som at der ikke finde..
16
26 okt
BAVA
Jeg synes du skulle lade være med at bekymre dig om kortsigtede udsving, og ganske enkelt gå lang i ..
16
29 okt
VWS
Hej Pokerchamp, det du kalder 'amatør-detektiv'-arbejde er langt mere informativt end dine ukonstruk..
14
28 okt
VWS
 Fredag d. 3. okt. i år var den norske Olie- og energiminister Tord Lien og næstformand for det nors..
14
29 okt
FING-B
Swift - det er jo fuldkommen ligegyldigt hvad vi siger eller gør så synes du og dit slæng det er for..
12
30 okt
VWS
Jeg sad ellers lige og kiggede endnu en ordre i Polen   34 MW Postolin Wind Farm   Den ordre må være..
11
30 okt
DANSKE
Og pludselig savner jeg alligevel den der "røde tommel ned"  der endgang var her på EI 
11
26 okt
 
Læg mærke til medierne altid fokuserer på de dårlige nyheder! Verden er af lava og vi hører konstant..
11

Aktier/tendens: C20 går grøn åbning i møde med TDC i rampelyset

31-10-2014 08:23:33
De europæiske aktiemarkeder ventes fredag at åbne med plus på hele linjen, og det ventes at smitte af herhjemme.Fredag vil TDC få en dag i rampelyset, da det da..

Schouw/CEO: Har flere opkøb i kikkerten

30-10-2014 15:39:25
Industrikonglomeratet Schouw & Co. har appetit på yderligere opkøb til sine porteføljevirksomheder.Det siger selskabets administrerende direktør Jens Bjerg Søre..

Novo/S&P Capital: Hæver kursmål til 273 kr. fra 253 kr.

30-10-2014 13:03:29
Analytikerne hos S&P Capital IQ er blevet mere positivt stemt over for Novo Nordisk-aktien.I hvert fald hæver finanshuset kursmålet til 273 kr. fra tidligere 25..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Coloplast Q4: Absolut ingen slinger i valsen
2
Novo/Swedbank: Sænker anbefaling og kursmål
3
Asien: Overraskende japansk beslutning trækker kraftigt op
4
Danske Bank: Analytikere finpudser kursmål efter regnskab
5
Novo/S&P Capital: Hæver kursmål til 273 kr. fra 253 kr.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
31. oktober 2014 09:25:22
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141028.2 - EUROWEB7 - 2014-10-31 09:25:22 - 2014-10-31 09:25:22 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x